Work

Is CBD ready for prime time in sickle cell disease?

Year: 2023

Type: editorial

Abstract: strategies tailored in particular to protect the most vulnerable subgroups of patients, including those with impaired immune function and at higher risk of dismal outcome upon infection.

Source: Blood

DOI: 10.1182/blood.2022018393

Authors: Susanna A. Curtis, Enrico M. Novelli

Institutions: Mount Sinai Hospital, University of Pittsburgh

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Heart, Lung, and Blood Institute

Awards: G4746380274, Dronabinol for the reduction of chronic pain and inflammation in people with sickle cell disease

OpenAlex ID: W4315752803

Cites: 10

Cited by:

Related to: 10